National Bank of Canada’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.24K Buy
1,246
+771
+162% +$8.11K ﹤0.01% 2357
2025
Q4
$5.58K Sell
475
-412
-46% -$4.45K ﹤0.01% 2419
2025
Q3
$6.84K Buy
887
+322
+57% +$2.25K ﹤0.01% 2406
2025
Q2
$4.13K Buy
565
+246
+77% +$1.99K ﹤0.01% 2523
2025
Q1
$3.02K Sell
319
-37
-10% -$462 ﹤0.01% 2453
2024
Q4
$5.87K Sell
356
-85
-19% -$1.32K ﹤0.01% 2422
2024
Q3
$6.5K Sell
441
-3,119
-88% -$48.8K ﹤0.01% 2162
2024
Q2
$49.6K Hold
3,560
﹤0.01% 1688
2024
Q1
$56.1K Buy
3,560
+3,000
+536% +$46.3K ﹤0.01% 1719
2023
Q4
$8.93K Hold
560
﹤0.01% 2193
2023
Q3
$6.66K Hold
560
﹤0.01% 2297
2023
Q2
$8.99K Hold
560
﹤0.01% 2217
2023
Q1
$9.74K Hold
560
﹤0.01% 2144
2022
Q4
$5.16K Hold
560
﹤0.01% 2322
2022
Q3
$5K Sell
560
-1,050
-65% -$10.4K ﹤0.01% 2342
2022
Q2
$13K Sell
1,610
-1,940
-55% -$18.5K ﹤0.01% 2197
2022
Q1
$43K Sell
3,550
-150
-4% -$3.16K ﹤0.01% 1921
2021
Q4
$126K Buy
+3,700
New +$145K ﹤0.01% 1576

Other funds holding NEO

National Bank of Canada's NEO Position: Q1 2026 in Review

National Bank of Canada increased its NeoGenomics (NEO) stake by 162% in Q1 2026, buying an estimated $8.11K and bringing the position to 1,246 shares worth $9.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2357.

National Bank of Canada first reported a position in NEO in Q4 2021 and has held it in 18 quarters since. The position peaked at $126K in Q4 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • National Bank of Canada held 1,246 shares of NeoGenomics worth $9.24K as of Q1 2026.
  • National Bank of Canada bought 771 NeoGenomics shares in Q1 2026, an estimated $8.11K.
  • NeoGenomics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2357 holding.
  • National Bank of Canada first reported a position in NeoGenomics in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's NeoGenomics position peaked at $126K in Q4 2021.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.